Evolent Health Inc (EVH)
22.88
-0.39
(-1.68%)
USD |
NYSE |
May 23, 16:00
22.88
0.00 (0.00%)
After-Hours: 16:12
Evolent Health Enterprise Value: 3.101B for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 3.101B |
| May 21, 2024 | 3.068B |
| May 20, 2024 | 3.059B |
| May 17, 2024 | 3.078B |
| May 16, 2024 | 3.106B |
| May 15, 2024 | 3.133B |
| May 14, 2024 | 3.168B |
| May 13, 2024 | 3.156B |
| May 10, 2024 | 3.238B |
| May 09, 2024 | 3.524B |
| May 08, 2024 | 3.560B |
| May 07, 2024 | 3.599B |
| May 06, 2024 | 3.557B |
| May 03, 2024 | 3.540B |
| May 02, 2024 | 3.576B |
| May 01, 2024 | 3.560B |
| April 30, 2024 | 3.656B |
| April 29, 2024 | 3.664B |
| April 26, 2024 | 3.646B |
| April 25, 2024 | 3.724B |
| April 24, 2024 | 3.833B |
| April 23, 2024 | 3.934B |
| April 22, 2024 | 3.902B |
| April 19, 2024 | 3.862B |
| April 18, 2024 | 3.875B |
| Date | Value |
|---|---|
| April 17, 2024 | 3.877B |
| April 16, 2024 | 3.937B |
| April 15, 2024 | 3.954B |
| April 12, 2024 | 3.934B |
| April 11, 2024 | 3.980B |
| April 10, 2024 | 3.922B |
| April 09, 2024 | 4.010B |
| April 08, 2024 | 3.930B |
| April 05, 2024 | 3.914B |
| April 04, 2024 | 3.851B |
| April 03, 2024 | 3.887B |
| April 02, 2024 | 3.910B |
| April 01, 2024 | 4.094B |
| March 31, 2024 | 4.192B |
| March 28, 2024 | 4.139B |
| March 27, 2024 | 4.132B |
| March 26, 2024 | 4.064B |
| March 25, 2024 | 4.094B |
| March 22, 2024 | 4.097B |
| March 21, 2024 | 4.117B |
| March 20, 2024 | 4.155B |
| March 19, 2024 | 4.077B |
| March 18, 2024 | 4.068B |
| March 15, 2024 | 4.123B |
| March 14, 2024 | 4.218B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
505.93M
Minimum
Mar 16 2020
4.751B
Maximum
May 01 2023
2.344B
Average
2.330B
Median
Enterprise Value Benchmarks
| American Shared Hospital Services | 31.45M |
| Novo Integrated Sciences Inc | 11.23M |
| Astrana Health Inc | 1.582B |
| Cryo-Cell International Inc | 83.06M |
| P3 Health Partners Inc | 391.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.28M |
| Revenue (Quarterly) | 639.65M |
| Total Expenses (Quarterly) | 644.15M |
| EPS Diluted (Quarterly) | -0.22 |
| Gross Profit Margin (Quarterly) | 16.28% |
| Profit Margin (Quarterly) | -2.70% |
| Earnings Yield | -5.46% |
| Normalized Earnings Yield | -3.329 |